InsidersTradesSigma
Track the ロート製薬株式会社 share price and the full management transaction log of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Food & Beverage sector, ロート製薬株式会社 has published 5 public disclosures. Market capitalisation: €539.7bn. The latest transaction was reported on 29 July 2024 (Holding update). Among the most active insiders: Massachusetts Financial Services Company. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,071 of 29,053 companies
68.4
score / 100
Value67
Quality70
FCF yld4.0%
Earn yld6.3%
EV/EBITDA9.2x
ROE12%
Gross mgn56%
Net mgn10.0%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 July 2024
Declarations5 total
ShareXTKSEDINET:S100U3FI
ShareXTKSEDINET:S100SBQ0
ShareXTKSEDINET:S100QS4B
ShareXTKSEDINET:S100Q9CV
100.0% of flowShareXTKSEDINET:S100Q5QK
5 of 5 declarations
关于 ロート製薬株式会社
乐敦制药株式会社（Rohto Pharmaceutical Co., Ltd.）是一家日本公司，专注于药品和保健产品的研发。该公司致力于开发创新产品，以促进消费者福祉。